Synapse - Antiviral Research

Antiviral Research

Published by: Elsevier Science, Inc.

People

Wendel
Nikolov

Groups

GSK Faculty (3)
Sloan Kettering Institute Faculty (3)
Cancer Biology and Genetics Program Faculty (2)
Sloan Kettering Institute Postdocs (1)
Structural Biology Program Faculty (1)

Search Within

Results (3)

Export to EndNote / Excel

The rocaglate CR-31-B (−) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo

Journal Article

Müller, C.; Obermann, W.; Karl, N.; Wendel, H. G.; Taroncher-Oldenburg, G.; Pleschka, S.; Hartmann, R. K.; Grünweller, A.; Ziebuhr, J.
Antiviral Research (2021)

Fulltext@MSK | Save

Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol

Journal Article

Müller, C.; Obermann, W.; Schulte, F. W.; Lange-Grünweller, K.; Oestereich, L.; Elgner, F.; Glitscher, M.; Hildt, E.; Singh, K.; Wendel, H. G.; more...
Antiviral Research (2020)

Fulltext@MSK | Save

A treatment for and vaccine against the deadly Hendra and Nipah viruses

Journal Article

Broder, C. C.; Xu, K.; Nikolov, D. B.; Zhu, Z. Y.; Dimitrov, D. S.; Middleton, D.; Pallister, J.; Geisbert, T. W.; Bossart, K. N.; Wang, L. F.
Antiviral Research (2013)

Fulltext@MSK | Save

Antiviral Research – authorized name for:

Name	ISSN / ISBN	Publisher
Antiviral Research	01663542	1992
Antiviral Research	01663542	Unknown
Antiviral Research	01663542	1990
Antiviral Research	0166-3542	Elsevier Science, Inc.
Antiviral Research	0166-3542	Elsevier Science, Inc.
Antiviral Research	0166-3542	Elsevier Science, Inc.
Antiviral Research	0166-3542	Elsevier Science, Inc.
Antiviral Research	0166-3542	Elsevier Inc.
Antiviral Research	0166-3542	Elsevier Science, Inc.
Antiviral Research	01663542	Elsevier B.V.
Antiviral Research	0166-3542	Elsevier B.V.
Antiviral Research	0166-3542	Elsevier B.V.